Beeping through chemo: can smarter alarms make infusions safer?

NCT ID NCT07718711

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This observational study watches healthcare workers during routine cancer drug infusions to track how often alarms—especially air-in-line alerts—go off and how staff handle them. Researchers will measure alarm frequency, response times, and user experience with different infusion technologies. The goal is to identify safety gaps and inform better alarm design, without giving any experimental treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If patterns emerge, this could point toward better alarm systems and safer infusion practices for cancer patients.
What could go wrong
This is a small observational study, not a controlled experiment, so it cannot prove that any change improves safety.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AIR-IN-LINE ALARM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • ASST Lodi

    Lodi, Lombardy, 26900, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • AUSL Parma

    Parma, Emilia-Romagna, 43126, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Fondazione Policlinico Universitario A. Gemelli IRCCS

    Rome, Lazio, 00168, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • IEO - Istituto Europeo di Oncologia

    Milan, Lombardy, 20141, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • IRCCS Ospedale San Raffaele

    Milan, Lombardy, 20132, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.